Position history for Rafferty Asset Management, LLC's holdings in BRIDGEBIO PHARMA INC
Rafferty Asset Management, LLC holds 63,180 shares of BBIO (BRIDGEBIO PHARMA INC), worth $4.7M as of 2026-Q1. The position was decreased (-21.0% shares). BBIO represents 0.0% of Rafferty Asset Management, LLC's portfolio.
Current Value
$4.7M
Current Shares
63,180
Total Value Change
-$2.2M
Total Shares Change
-208,427
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC
Decreased |
| 63,180 |
-21.0% |
| $4.7M |
| 0.0% |
| $64.53 |
0 |
| 2025-Q4 | Decreased | 80,018 | -47.4% | $6.1M | 0.0% | $75.48 | 0 |
| 2025-Q3 | Decreased | 151,990 | -22.8% | $7.9M | 0.0% | $51.96 | 0 |
| 2025-Q2 | Decreased | 196,782 | -2.6% | $8.5M | 0.0% | $44.86 | 0 |
| 2025-Q1 | Decreased | 202,128 | -19.2% | $7M | 0.0% | $35.11 | 0 |
| 2024-Q4 | Increased | 250,242 | +2.8% | $6.9M | 0.0% | $27.32 | 28 |
| 2024-Q3 | Decreased | 243,331 | -10.4% | $6.2M | 0.0% | $24.94 | 0 |
| 2024-Q2 | Decreased | 271,607 | -14.2% | $6.9M | 0.0% | $25.33 | 0 |